Insulin-like peptide 3 (INSL3), a major product of testicular Leydig cells, is also expressed by the ovary, but its functional role remains poorly understood. Here, we quantified expression of INSL3 and its receptor RXFP2 in theca interna cell (TIC) and granulosa cell compartments of developing bovine antral follicles and in corpora lutea (CL). INSL3 and RXFP2 mRNA levels were much higher in TIC than granulosa cell and increased progressively during follicle maturation with INSL3 peaking in large (11-18 mm) estrogen-active follicles and RXFP2 peaking in 9-to 10-mm follicles before declining in larger (11-18 mm) follicles. Expression of both INSL3 and RXFP2 in CL was much lower than in TIC. In situ hybridization and immunohistochemistry confirmed abundant expression of INSL3 mRNA and protein in TIC. These observations indicate follicular TIC rather than CL as the primary site of both INSL3 production and action, implying a predominantly autocrine/paracrine role in TIC. To corroborate the above findings, we showed that in vitro exposure of TIC to a luteinizing concentration of LH greatly attenuated expression of both INSL3 and its receptor while increasing progesterone secretion and expression of STAR and CYP11A1. Moreover, in vivo, a significant cyclic variation in plasma INSL3 was observed during synchronized estrous cycles. INSL3 and estradiol-17␤ followed a similar pattern, both increasing after luteolysis, before falling sharply after the LH surge. Thus, theca-derived INSL3, likely from the dominant preovulatory follicle, is detectable in peripheral blood of cattle, and expression is down-regulated during luteinization induced by the preovulatory LH surge. Collectively, these findings underscore the likely role of INSL3 as an important intrafollicular modulator of TIC function/steroidogenesis, while raising doubts about its potential contribution to CL function. (Endocrinology 154: 1897-1906, 2013) 
Insulin-like peptide 3 (INSL3), a major product of testicular Leydig cells, is also expressed by the ovary, but its functional role remains poorly understood. Here, we quantified expression of INSL3 and its receptor RXFP2 in theca interna cell (TIC) and granulosa cell compartments of developing bovine antral follicles and in corpora lutea (CL). INSL3 and RXFP2 mRNA levels were much higher in TIC than granulosa cell and increased progressively during follicle maturation with INSL3 peaking in large (11-18 mm) estrogen-active follicles and RXFP2 peaking in 9-to 10-mm follicles before declining in larger (11-18 mm) follicles. Expression of both INSL3 and RXFP2 in CL was much lower than in TIC. In situ hybridization and immunohistochemistry confirmed abundant expression of INSL3 mRNA and protein in TIC. These observations indicate follicular TIC rather than CL as the primary site of both INSL3 production and action, implying a predominantly autocrine/paracrine role in TIC. To corroborate the above findings, we showed that in vitro exposure of TIC to a luteinizing concentration of LH greatly attenuated expression of both INSL3 and its receptor while increasing progesterone secretion and expression of STAR and CYP11A1. Moreover, in vivo, a significant cyclic variation in plasma INSL3 was observed during synchronized estrous cycles. INSL3 and estradiol-17␤ followed a similar pattern, both increasing after luteolysis, before falling sharply after the LH surge. Thus, theca-derived INSL3, likely from the dominant preovulatory follicle, is detectable in peripheral blood of cattle, and expression is down-regulated during luteinization induced by the preovulatory LH surge. Collectively, these findings underscore the likely role of INSL3 as an important intrafollicular modulator of TIC function/steroidogenesis, while raising doubts about its potential contribution to CL function. (Endocrinology 154: 1897-1906, 2013) I nsulin-like peptide 3 (INSL3) is a member of the relaxininsulin family of peptide hormones and is a major secretory product of the testicular Leydig cells of male mammals (1) (2) (3) . In the adult male, it is produced in large quantities, in a constitutive manner, and gives rise to substantial concentrations in the peripheral circulation. It is a good marker for fully differentiated Leydig cells and is likely to play a role in maintaining spermatogenesis (2) . In the male fetus, INSL3 is an important product of the fetal Leydig cells and is instrumental in the transabdominal phase of testicular descent (4) . Hence, the principal phenotype of male Insl3 knockout mice is primary cryp-torchidism (5, 6) . INSL3 signals through a G protein-coupled receptor known as relaxin family peptide receptor (RXFP)2 (7), which is closely related to the relaxin receptor RXFP1. Mice lacking RXFP2 exhibit the same cryptorchid phenotype as that of Insl3 knockout mice (8, 9) .
Although INSL3 has principally been described as a male hormone, it is also expressed in the adult female, by follicular theca cells and corpus luteum (CL) of the ovary (10 -16) . The role of INSL3 in the female is not well defined. However, there is evidence to suggest that it is involved in postpubertal follicular selection and maturation. INSL3 knockout mice have been found to display impaired fertility and have higher rates of follicular atresia and fewer ovulations than their wild-type littermates (5, 17) . It has been suggested that INSL3 is a marker of differentiated theca cells and can be modulated by factors that influence follicle differentiation, such as IGF, insulin, and LH (14, 18) . Levels have also been shown to decline in atretic follicles (14) .
INSL3 has been detected in the peripheral blood of adult women but at much lower levels than in men (19, 20) , perhaps indicating that it plays a local intraovarian role rather than a systemic endocrine role in the female (2) . However, in ruminants, ovarian expression levels are considerably higher than in other mammals, and this may indicate that it also plays a systemic role in these species (11, 18) .
The aims of the present study were, firstly, to perform a detailed analysis of the expression of INSL3 and its receptor RXFP2 in bovine ovarian follicles, spanning key stages of antral follicle development, including cyclic recruitment, selection/deviation, luteinizing hormone/choriogonadotropin receptor (LHCGR) acquisition, and dominance, in order to further define the role of INSL3 during follicle development and to identify the target of its action. Secondly, we examined expression of INSL3 and RXFP2 in luteal tissue. Thirdly, bovine theca interna cells (TICs) in primary culture were used to determine the effect of LH-induced luteinization on expression of INSL3 and RXFP2. Finally, circulating plasma levels of INSL3 throughout the bovine oestrus cycle were measured for the first time using a recently developed timeresolved fluorescence immunoassay (21) in order to examine whether there is cyclic variation in INSL3 and to correlate this information with the results from the above-mentioned follicular expression profiling and in vitro experimentation.
Materials and Methods

Bovine ovaries
Ovaries from nonpregnant adult cattle slaughtered at random stages of the estrous cycle were collected from a local abattoir.
They were transported to the laboratory in medium-199 supplemented with 1% (vol/vol) antibiotic antimycotic solution. For in situ hybridization, ovaries were snap frozen in isopentane on dry ice immediately after collection. For immunohistochemistry, fresh follicular tissues were immersion fixed in Bouin's fixative for 6 hours, followed by graded ethanols and embedding in paraffin wax. As control tissues, testis fragments from sexually mature animals were similarly processed.
Preparation of granulosa cell (GC) and TIC extracts for gene expression analysis
Follicles ranging in diameter from 1 to 18 mm were dissected from ovaries that were judged to be from cattle in the mid to late-luteal phase, as described in detail elsewhere (22) . Estimation of cycle stage was based on the morphological appearance of the CL (23) . Follicles were sorted by size, and their GC, TIC layers, and follicular fluid were recovered. Isolated GCs and TICs were homogenized in 0.5 mL of Trireagent (Sigma UK Ltd, Poole, United Kingdom) and stored at Ϫ80°C before RNA extraction. Concentrations of estradiol-17␤ (E2) and progesterone in follicular fluid were determined by immunoassay. Follicles in the largest size category (11-18 mm) were subdivided according to their follicular fluid E2 to progesterone (P4) ratio, with those with E2 to P4 ratio more than 1 being presumed healthy, "estrogen-active" dominant follicles, and those with E2 to P4 ratio less than 1 being presumed to be "estrogen inactive" and regressing (22) .
Isolation of CL samples for gene expression analysis
Samples of CL tissue were isolated from the ovaries and were categorized as being "early-luteal," "midluteal," and "late-luteal" phase, according to the criteria described by Ireland et al (23) . CL samples were snap frozen on dry ice and stored at Ϫ80°C before subsequent RNA extraction using Trireagent.
In vitro TIC luteinization model
TICs were isolated from the ovaries as described previously (24) . For each experiment, TICs were pooled from around 50 follicles of 4 -6 mm in diameter and were plated at a density of 500 000 viable cells/well in 24-well plates (Nunclon, Life Technologies Ltd, Carlsbad, California). Serum-free culture medium was used throughout: McCoy's 5A with 1% (vol/vol) antibioticantimycotic solution, 10-ng/mL bovine insulin, 2mM L-glutamine, 10mM HEPES, 5-mg/mL apotransferrin, 5-ng/mL sodium selenite, and 0.1% (wt/vol) BSA. Cells were cultured for 6 days (removing and replacing with fresh media every 48 h) at 38.5°C in the presence or absence of a luteinizing dose level (1.5 ng/mL) of ovine LH (NIADDK oLH-S16; obtained from NHPP, Torrance, California). At the end of the culture, conditioned media were retained for P4 and INSL3 immunoassays, and cell lysates were prepared using the lysis buffer supplied with the RNeasy extraction kit (Buffer RLT; QIAGEN Ltd, Manchester, United Kingdom), according to the manufacturer's instructions. Lysates from replicate wells were pooled and stored at Ϫ80°C before RNA extraction. The experiment was repeated 4 times with independent batches of ovaries.
In vivo studies in prostaglandin (PG)-synchronized heifers
The 5 British Friesian heifers (ϳ2 y old; ϳ400-kg body weight) used in this study were housed indoors, loosely tethered in individual stands. They were fed a maintenance ration of concentrates and straw and had continual access to water. Estrous cycles were synchronized by giving 3 injections (im) of the PG F 2␣ analog cloprostenol (0.5 mg), 14 days apart. The day of the third PG injection was designated as day 0 of the study. Two further PG injections were given on days 14 and 28 to induce luteolysis, resulting in 3 truncated cycles being studied per cow (n ϭ 15 cycles in total). Blood samples (50 mL) were taken on a daily basis via a jugular vein catheter that was flushed with sterile 0.9% wt/vol saline containing sodium heparin (100 IU/mL) after sample withdrawal. Samples were collected into polypropylene tubes containing 50 L of sodium heparin (5000 IU/mL). After centrifugation (2000g for 30 min), plasma was decanted and stored at Ϫ20°C awaiting hormone analysis. The experiment was carried out in full compliance with United Kingdom Home Office guidelines and the Animals (Scientific Procedures) Act 1986.
Does E2 directly alter expression of INSL3 or RXFP2 expression by nonluteinized TIC?
To test whether direct exposure on nonluteinized TIC to E2 could affect expression of mRNAs for INSL3 or RXFP2, isolated TICs were cultured with a concentration of LH (150 pg/mL) conducive to optimal androstenedione secretion (24) in the presence and absence of E2 at a concentration (500 ng/mL) comparable with that present in follicular fluid from preovulatory bovine follicles. At the end of culture, conditioned media were retained for androstenedione assay and cell lysates prepared for RNA extraction and real-time PCR analysis. The experiment was repeated 4 times with cells from independent batches of ovaries.
E2, P4, and androstenedione immunoassays
Plasma E2 concentrations were determined by RIA as described previously (25, 26) , with an assay detection limit of 1.7 pg/mL and intra-and interassay coefficients of variation of 11% and 15%, respectively. Concentrations of P4 in plasma and cellconditioned culture media were determined by direct ELISA (27) (28) (29) . Intra-and interassay coefficients of variation were 9% and 13%, respectively, and the detection limit was 20 pg/mL. Plasma androstenedione levels were measures by ELISA as described elsewhere (30) . Before analysis, androstenedione was extracted from the plasma using ethyl ether. Briefly, 5 volumes of ethyl ether were added to 500-L plasma in glass tubes. Tubes were vortexed for 1 minute and left to stand for 10 minutes to allow the 2 phases to separate. The upper ethyl ether phase was transferred to a clean glass tube and allowed to evaporate to dryness. The extracted steroid was then redissolved in assay diluent (PBS containing 0.1% wt/vol gelatin and 0.05% vol/vol Proclin 300). Androstenedione standards were made up in charcoal-stripped cow plasma and were ether extracted in parallel with experimental plasma samples. Androstenedione levels in the extracted samples were then measured by competitive ELISA (30), using the extracted standards to calibrate the assay, hence avoiding the need to correct for recoveries. The goat antiandrostenedione antibody (IR637) used in the assay was kindly provided by Dr G. S. Pope (Institute for Grassland and Environmental Research, Hurley, United Kingdom), and androstenedione-horseradish peroxidase conjugate was purchased from Cal Bioreagents (Los Angeles, California). Intra-and interassay coefficients of variation were 7% and 12%, respectively.
INSL3 assay
Concentrations of INSL3 in plasma and TIC-conditioned media were determined using a novel time-resolved fluorescence immunoassay, which is highly specific for ruminant INSL3 and is described in detail elsewhere (21) . As tracer for the assay, synthetic bovine INSL3 (A-chain/B-chain heterodimer) was labeled with (Eu 3ϩ ) chelate (see Supplemental Table 1 , published on The Endocrine Society's Journals Online web site at http:// endo.endojournals.org). The assay detection range was from 0.02 to 20.0 ng/mL of bovine INSL3. Intra-and interassay coefficients of variation were 2% and 10%, respectively.
RNA isolation
Total RNA was isolated from TIC lysates using the RNeasy kit (QIAGEN Ltd), according to the manufacturer's instructions and the RNA eluted in 30 L of nuclease-free water. On-column deoxyribonuclease (DNase) digestion was performed using ribonuclease-free DNase (QIAGEN Ltd) to remove any potential DNA contamination. Total RNA was isolated from ex vivo GC, TIC, and CL samples, using Trireagent (Sigma UK Ltd), as described previously (22, 31) , and potential genomic DNA contamination was removed with an ribonuclease-free DNase kit (RQ1; Promega UK Ltd, Southampton, United Kingdom). RNA quantity and quality were evaluated by spectrophotometry at 260/280 nm.
cDNA synthesis and real-time PCR
cDNA was synthesized from 1 g of RNA using the Reverse-iT RT kit (Abgene, Epsom, United Kingdom) according to the manufacturer's instructions. Primers (see Table 1 ) were designed using Primer Express software (version 1.5; PerkinElmerApplied Biosystems, Warrington, United Kingdom) and primer- 
In situ hybridization
Frozen sections (25 m) were cut using a cryostat, thaw mounted, and stored at Ϫ80°C until required. For in situ hybridization sense and antisense riboprobes labeled with digoxygenin were synthesized by in vitro transcription with T7 and T3 RNA polymerase (Promega, Madison, Wisconsin) from nucleotides 96-431 of the INSL3 gene (accession number NM_174365) cloned into pBluescript (Stratagene, La Jolla, California). After synthesis, the probes were checked for integrity by denaturing gel electrophoresis and purified using the RNeasy kit (QIAGEN Ltd). Frozen slides were rapidly thawed and fixed for 20 minutes in 4% (wt/vol) paraformaldehyde in PBS at 4°C. After proteinase K treatment (20 min at 37°C), sections were hybridized overnight at 65°C with either the sense or antisense riboprobe. After washing the sections, hybridized probe was detected using an alkaline phosphatase-conjugated antidigoxygenin antibody and visualized using NBT/BCIP alkaline phosphatase substrate (Roche Molecular Biochemicals, Indianapolis, Indiana). Cryostat sections of frozen bovine testis were included as a positive control, and sense probes were included to determine nonspecific background labeling.
Immunohistochemistry
Eight-micrometer paraffin sections of bovine follicular and testis tissues were dewaxed and subjected to immunohistochemistry after the double peroxidase-antiperoxidase-avidin-biotincomplex protocol as previously described (33) , with diaminobenzidine (Sigma UK Ltd) as chromogen. As primary antibody, the polyclonal antiserum (AS 33) raised in rats against a recombinant bovine pro-INSL3 protein made in Escherichia coli was used, as previously described and validated (14) , at a dilution of 1:1000. Sections were briefly counterstained using Light Green and mounted in aqueous mounting medium.
Statistical analysis
Real-time PCR data were analyzed as ⌬Ct values before conversion to fold difference values, and results were analyzed using 1-or 2-way ANOVA. Post hoc pairwise comparisons referred to in results were made by Fisher's protected least significant difference (PLSD) test. For in vitro experiments, results presented are combined data from 4 independent cultures. Statistical analysis of plasma hormone concentrations was performed by repeated measures ANOVA. Providing a significant "F' ratio was recorded post hoc Fisher's PLSD test was used for individual pairwise comparisons between different time points.
Results
Changes in INSL3 and RXFP2 mRNA expression in developing follicles and in CL
Mean Ct values for ACTB (␤-actin), INSL3, and RXFP2 were, respectively, 16.1, 16.8, and 25.5 for TIC, 15.3, 20.5, and 31.9 for GC, and 15.6, 21.3, and 33.4 for CL samples. As shown in Figure 1 , the relative abundance of mRNA for INSL3 and its receptor RXFP2 was much greater in TIC than GC across all follicle size categories (2-way ANOVA effect of cell type: INSL3, P Ͻ .001; RXFP2, P Ͻ .0001). Levels of both transcripts varied significantly according to follicle size (2-way ANOVA effect of size class: INSL3, P Ͻ .05; RXFP2, P Ͻ .001). INSL3 mRNA level in the TIC layer showed a progressive 5-fold increase as follicles developed from 1-2 to 11-18 mm and was greatest in the 11-to 18-mm estrogen-active follicles. Expression level was approximately 50% lower in estrogen inactive than estrogen-active follicles of this size category (P Ͻ .05; post hoc PLSD test). RXFP2 expression in TIC also increased as follicles developed from 1-2 to 9 -10 mm, before decreasing again in both estrogen-active and estrogen-inactive 11-to 18-mm follicles. There was a highly significant positive correlation (r ϭ 0.81, P Ͻ .001, n ϭ 47) between the relative mRNA abundance of INSL3 and CYP17 in the TIC compartment of follicles of 1-18 mm in diameter (Figure 2 ).
INSL3 and RXFP2 were also expressed in CL tissue (Figure 3) , with the relative expression of INSL3 being significantly higher in the midluteal stage than in regressing CL samples (P Ͻ .05). However, relative to ␤-actin, levels of INSL3 mRNA were much lower in CL tissue than in follicular TIC samples (6-to 30-fold lower depending on follicle size class used for comparison).
In situ hybridization: localization of INSL3 mRNA in ovary sections
The mRNA expression data above showing that INSL3 was mainly expressed in the thecal compartment was confirmed by in situ hybridization. Figure 4A shows that the intensity of staining for INSL3 mRNA was much greater in the theca layer, with little staining in the GC layer or surrounding stromal tissue. The specificity of the hybridization probe for INSL3 was confirmed by the absence of staining in the sense controls and by the specific staining of Leydig cells in testis sections, a cell type known to abundantly express INSL3 (2, 3).
Immunohistochemical localization of INSL3 protein in ovary sections
The above quantitative PCR and in situ hybridization data were further confirmed by immunohistochemical staining of INSL3 protein. Figure 4B shows that the intensity of staining for INSL3 was much greater in the TIC layer, with little staining in the GC layer. The specificity of the antibody for INSL3 was confirmed by the specific staining of Leydig cells in testis sections.
In vitro TIC luteinization model
The effect of exposing cultured bovine TIC to a luteinizing dose of LH on INSL3 and RXFP2 expression was examined. LH treatment for 4 days resulted in a more than 100-fold increase (P Ͻ .001) in the amount of progesterone secreted by the cells and a corresponding increase in the relative expression of transcripts for STAR (P Ͻ .001) and P450SCC (P Ͻ .05), indicative of functional luteinization ( Figure 5 ). In contrast, LH-induced luteinization was associated with a marked decrease in the secretion of INSL3 protein (P Ͻ .01) and relative abundance of INSL3 and RXFP2 transcripts (P Ͻ .01 and P Ͻ .001, respectively). Figure 6 shows mean daily plasma hormone profiles from 5 heifers (n ϭ 15 cycles) sampled during PG-synchronized estrous cycles. Repeated measures ANOVA revealed a significant variation over time in plasma INSL3, E2, and P4 (P Ͻ .001), whereas plasma androstenedione levels did not vary significantly (P ϭ .35). As expected, P4 levels fell steeply after PG, remaining low until endo.endojournals.orgday 6 when the new CL was forming. Plasma E2 levels increased after PG induced luteolysis (d 0) and peaked on day 2-3, shortly before the preovulatory LH surge (d 3.5 Ϯ 0.6). INSL3 levels followed a similar pattern to E2, increasing by 38% (P Ͻ .05) from 62.9 pg/mL on day 0 to 86.6 pg/mL on day 2. Levels then fell by 54% to 39.8 pg/mL on day 4 (P Ͻ .001), coincident with the post-LH surge decline in E2.
Plasma steroid and INSL3 profiles during PG-synchronized estrous cycles
Does E2 directly alter expression of INSL3 or RXFP2 by nonluteinized TIC?
Given the above in vivo observation, we examined whether E2 could directly affect expression of INSL3 or its receptor RXFP2 by isolated TIC cultured under nonluteinizing conditions. As shown in Figure 7 , treatment with E2 promoted a modest increase in androstenedione secretion (ϳ50%; P Ͻ .05) but did not affect the relative abundance of INSL3 or RXFP2 transcripts.
Discussion
INSL3-null female mice have been shown to display impaired fertility (5, 17) . However, there is a paucity of data regarding the ovarian expression pattern and potential role(s) of INSL3-RXFP2 signaling in follicle development, steroidogenesis, and CL function. Given reports that the ovarian expression of INSL3 is considerably higher in ruminants than in nonruminant mammals (11, 18) , in the first part of this study, we used real-time PCR to quantify the patterns of RNA expression for INSL3 and its receptor RXFP2 in the theca interna and granulosal compartments of developing bovine antral follicles and in early, midluteal, and regressing CL. Overall, the relative abundance of INSL3 mRNA was found to be much greater in TIC than GC, an observation we confirmed by both in situ hybridization and by immunohistochemistry demonstrating expression at the translated protein level. This finding is consistent with previous studies showing that INSL3 is expressed predominantly by TIC (11, 14, 18) . Our comparison of follicles of various size categories ranging from 1-2 to 11-18 mm revealed for the first time that INSL3 expression increases progressively with follicle development, peaking in preovulatory stage follicles of 11-18 mm. Furthermore, when follicles of this size category were subdivided according to their E2 to P4 ratio (34), the INSL3 transcript level was significantly lower (ϳ50%) in the estrogen-inactive follicles (presumed to be regressing) than in the estrogen-active follicles (presumed to be healthy). The latter observation is consistent with an earlier report (14) that INSL3 expression levels were significantly decreased in atretic follicles. In the same study, pro-INSL3 protein was detected by immunohistochemistry in 100% of the small morphologically healthy follicles (2-5 mm) but in only 57% of morphologically healthy preovulatory follicles (12-17 mm) examined. It is unclear whether an absence of detectable staining reflects the limit of sensitivity of the method used or a genuine absence of translated INSL3 protein. A detailed immunohistochemical analysis of INSL3 expression at the protein level in follicles at different stages of development was beyond the scope of the present study.
We also found that expression of RXFP2, the cognate receptor for INSL3, was also substantially (ϳ50-fold) higher in the thecal than granulosal compartment. Moreover, thecal RXFP2 expression, like INSL3, showed a marked and progressive increase during follicle maturation. In contrast to INSL3 levels, however, RXFP2 levels peaked in 9-to 10-mm follicles, before declining approximately 5-fold in larger (11-18 mm) follicles, regardless of their estrogenic status. These novel findings on the intrafollicular distribution and pattern of change of INSL3 and RXFP2 expression support the concept that theca-derived INSL3 functions primarily as an autocrine/paracrine regulator of theca cell function. However, given that a substantial fall in RXFP2 mRNA level was evident in large estrogen-active (11-18 mm) follicles expressing the highest levels of INSL3 mRNA, this might imply that INSL3-RXFP2 signaling is actually maximal in the smaller 9-to 10-mm size class. Interestingly, acquisition of LH receptors by GC only occurs in bovine follicles growing beyond about 9 mm in diameter (35, 36) , presaging their transition into estrogen-active preovulatory follicles capable of triggering, and ovulating in response to, an LH surge (37, 38) .
Because estrogen-active preovulatory follicles have the greatest requirement for theca-derived androgen as an essential substrate for cytochrome P450 aromatase (39) , one might expect that regulatory mechanisms conducive to sustained (or heightened) thecal androgen production would prevail in preovulatory follicles. Indeed, as reviewed elsewhere (40), a plethora of local factors have been identified as positive regulators of thecal androgen production, including IGF (41, 42) , inhibin (43) (44) (45) , and E2 itself (45, 46) , the latter 2 produced in greatest amounts by GC of preovulatory follicles. Conversely, other intraovarian factors, including TGF-␤ (47), activins (44, 48) , bone morphogenetic proteins (22, 24, 49) , TNF-␣ (50), epidermal growth factor, and TGF-␣ (51), have been shown to suppress androgen produc- tion. This begs the question: Is there any evidence that INSL3-RXFP2 signaling contributes to the autocrine/paracrine regulation of thecal androgen production?
The much higher levels of expression of both INSL3 and its receptor in the theca interna compartment in comparison with granulosal and luteal tissue suggest that INSL3 acts in an autocrine/paracrine manner within the follicle, being both predominantly produced by and acting upon TIC. In the male, an autocrine role for INSL3 has recently been described in mice, where both INSL3 and RXFP2 were found to be expressed in testicular Leydig cells. Treatment of cultured Leydig cells with INSL3 was found to stimulate testosterone and cAMP secretion (52) . In the present study, INSL3 mRNA expression was positively correlated with CYP17A1 expression, whose gene product (cytochrome P450 17␣-hydroxylase/17,20 lyase) is a key enzyme responsible for conversion of progestins to androgens. Furthermore, in our cultured TIC model, addition of a luteinizing dose of LH, known to suppress androgen production by ovarian theca cells (53, 54) , dramatically increased expression of STAR and CYP11A1 mRNA and raised progesterone secretion concomitantly with reduced INSL3 secretion and reduced expression of INSL3 and RXFP2 mRNA. In addition, we have recently demonstrated (30) that RNA interference-mediated knock down of either INSL3 or RXFP2 expression in nonluteinized bovine TIC promotes a marked reduction in CYP17A1 expression and androstenedione secretion. Collectively, these observations reinforce the notion that INSL3 is positively associated with follicular androgen production. Indeed, recent studies have found that INSL3 is elevated in the plasma of women with polycystic ovary syndrome and that levels in women with this syndrome are associated with ovarian hyperandrogenism (13, 20, 55) .
INSL3 expression by bovine CL has been reported previously (11, 18, 21) , but expression of its receptor RXFP2 was not documented in these reports. In the present study, both INSL3 and RXFP2 mRNAs were detected in CL, although relative expression levels (normalized to ␤-actin) were, respectively, more than 10-and more than 100-fold lower than in TIC, perhaps indicating that functional INSL3-RXFP2 signaling is only weakly operational in CL tissue. Consistent with previous studies (11, 18) , mean INSL3 mRNA level was greatest in midluteal samples but declined more than 10-fold in regressing CL.
To corroborate the above findings of 1) increased TIC expression of INSL3 during antral follicle development, 2) reduced INSL3 mRNA expression in luteal tissue, and 3) reduced INSL3 expression in TIC luteinized in vitro by exposure to high levels of LH, we used our novel bovine INSL3 immunoassay (21) to monitor, for the first time, circulating levels during PG-synchronized estrous cycles in cattle. We found a significant cyclic variation in plasma INSL3 concentrations during the bovine estrous cycle, with INSL3 following a similar profile to E2, increasing to maximal levels approximately 2 days after PG-induced luteolysis but then falling sharply after the ovulation-inducing LH surge on day 3-4 after PG injection. As expected, P4 fell steeply after PG induced luteolysis and did not rise again until 7 days later when a new CL was forming from the postovulatory follicle. It is notable that INSL3 levels did not fall in tandem with P4 after luteolysis, or rise with P4 during formation of the new CL. This further supports our finding that INSL3 is predominantly expressed by follicular theca interna cells of healthy preovulatory follicles, with much lower expression by CL. Taken together, these results strongly support the view that circulating INSL3 is a good biomarker for antral follicle development, at least during the first wave of a synchronized cycle. In agreement with the finding of others (56, 57) , plasma androstenedione levels did not vary significantly during the cycle, presumably because considerable amounts of the steroid present in the circulation emanate from follicles other than the dominant preovulatory follicle, and because some androstenedione is aromatized to estrogen. Further, some of the androstenedione in peripheral blood plasma is likely to be of adrenal origin. Finally, our observation that plasma INSL3 and E2 levels followed a similar profile after PG-induced luteolysis prompted us to examine whether direct exposure of cultured theca cells to E2, at a concentration comparable with intrafollicular concentrations in preovulatory follicles, could up-regulate INSL3 expression. Although E2 promoted a modest increase in androstenedione secretion, consistent with previous reports for cattle and human theca cells (45, 58) , there was no effect on expression of INSL3 or its receptor. Therefore, it remains to be investigated what the signal(s) are that lead to increased thecal INSL3 expression during the latter stages of follicle development.
In conclusion, we have shown that much higher levels of INSL3 are produced by TIC than by the GC or CL and that expression levels increase progressively throughout antral follicle development. Moreover, follicular theca interna cells are the likely site of both production and action of INSL3 within the ovary. Our data indicate that cyclic changes in predominantly theca-derived INSL3, rather than CL-derived INSL3, likely from the dominant preovulatory follicle, are detectable in peripheral blood of cattle. Both in vitro and in vivo studies indicate that the expression of INSL3 is downregulated during luteinization induced by the preovulatory LH surge. The positive correlation observed between INSL3 and CYP17A1 expression firmly indicates that INSL3 production within the ovary is linked to androgen production. Further investigation into the modulatory effects of INSL3 on thecal steroidogenesis will be of considerable interest, particularly in the context of ovarian androgen excess associated with conditions such as polycystic ovary syndrome.
